KaliVir Immunotherapeutics was founded in 2019 to pioneer a unique and novel approach to cancer treatment that engages a virus’ natural ability to replicate in and kill cancer cells

Pharmaceutical

KaliVir Immunotherapeutics

KaliVir Immunotherapeutics' headquarters in Pittsburgh, PA, United States

Helena Chaye

Adina Pelusio

Stephen H. Thorne

James M. Burke

Richard Jones

Tom Leonard

Lisa Butterfield

Greg Delgoffe

Jorge Nieva

Jonathan Rosenberg

Terry Hermiston

Dmitriy Zamarin

Jon Wigginton

Mitesh Borad

Tullia Bruno

Kurt Rote

The Laboratory and Quality Control team at KaliVir Immunotherapeutics ensures the reliability, safety, and efficacy of their pioneering cancer treatments. They conduct rigorous testing, oversee laboratory operations, maintain high standards of quality control, and manage documentation to support the development and validation of viral therapies aimed at targeting and eradicating cancer cells.

Laboratory and Quality Control

The Operations team at KaliVir Immunotherapeutics oversees the seamless execution of day-to-day activities, ensuring adherence to Good Manufacturing Practices (GMP), process optimization, and technical support. Their efforts are crucial in maintaining high standards and enabling effective manufacturing and development of innovative cancer treatments.

Operations

The Advisory Team at KaliVir Immunotherapeutics provides expert guidance on scientific and clinical strategies to enhance the development and application of the company's novel virus-based cancer treatments. Comprising primarily of Scientific and Clinical Advisors, the team ensures rigorous and innovative approaches are employed to maximize therapeutic efficacy and patient outcomes.

Advisory Team

The Leadership Team at KaliVir Immunotherapeutics is responsible for defining the strategic direction of the company, overseeing clinical development, and guiding scientific innovation in cancer treatment. Comprising key executives such as the CEO, CMO, and CSO, the team collaborates to ensure the successful advancement of novel immunotherapeutic approaches, aligning the company's vision with regulatory compliance and market needs. Their collective expertise drives research initiatives, business development, and stakeholder engagement to position KaliVir as a leader in the field of cancer therapeutics.

KaliVir Immunotherapeutics

Org chart

Board & advisors

Teams

Laboratory and Quality Control

Operations

Advisory Team

Leadership Team

Offices

KaliVir Immunotherapeutics

Org chart

Board & advisors

Teams

Laboratory and Quality Control

Operations

Advisory Team

Leadership Team

Offices

Related companies